PMID- 28973679 OWN - NLM STAT- MEDLINE DCOM- 20190916 LR - 20190916 IS - 1524-4040 (Electronic) IS - 0148-396X (Linking) VI - 83 IP - 2 DP - 2018 Aug 1 TI - The Minimal Clinically Important Difference of the Anterior Skull Base Nasal Inventory-12. PG - 277-280 LID - 10.1093/neuros/nyx401 [doi] AB - BACKGROUND: The minimal clinically important difference (MCID) is defined as the smallest change in health-related quality of life (QOL) that patients consider meaningful. The MCID is essential for determining clinically significant changes, rather than simply statistically significant changes, in QOL scores. The Anterior Skull Base Nasal Inventory-12 (ASK Nasal-12), a site-specific sinonasal QOL instrument, has emerged as a standard instrument for assessing QOL in patients who have undergone endonasal transsphenoidal surgery. OBJECTIVE: To determine the MCID for the ASK Nasal-12. METHODS: Distribution- and anchor-based methods were used to determine the MCID for the ASK Nasal-12 based on raw data from a multicenter prospective QOL study of 218 patients. RESULTS: Two distribution-based statistical methods, the one-half standard deviation method and the effect-size method, both yielded MCIDs of 0.37 (medium effect). The first anchor-based method, using the 2-wk postoperative overall nasal functioning item as the anchor, yielded an MCID of 0.31. The second anchor-based method, using the 2-wk postoperative Short Form Health Survey 8 bodily pain item as the anchor, yielded an MCID of 0.29. CONCLUSION: The largest MCID obtained for the ASK Nasal-12 using 4 statistical methods 2 wk postoperatively was 0.37. This information provides clinicians with an essential context for determining the clinical significance of changes in QOL scores after interventions. Our results will help clinicians better interpret QOL scores and design future studies that are powered to detect meaningful QOL changes. FAU - Gravbrot, Nicholas AU - Gravbrot N AD - Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hos-pital and Medical Center, Phoenix, Ari-zona. FAU - Kelly, Daniel F AU - Kelly DF AD - Pacific Pituitary Disorders Center, John Wayne Cancer Institute, Saint John's Health Center, Santa Monica, California. FAU - Milligan, John AU - Milligan J AD - Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hos-pital and Medical Center, Phoenix, Ari-zona. FAU - Griffiths, Chester F AU - Griffiths CF AD - Pacific Pituitary Disorders Center, John Wayne Cancer Institute, Saint John's Health Center, Santa Monica, California. FAU - Barkhoudarian, Garni AU - Barkhoudarian G AD - Pacific Pituitary Disorders Center, John Wayne Cancer Institute, Saint John's Health Center, Santa Monica, California. FAU - Jahnke, Heidi AU - Jahnke H AD - Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hos-pital and Medical Center, Phoenix, Ari-zona. FAU - White, William L AU - White WL AD - Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hos-pital and Medical Center, Phoenix, Ari-zona. FAU - Little, Andrew S AU - Little AS AD - Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hos-pital and Medical Center, Phoenix, Ari-zona. LA - eng PT - Journal Article PT - Multicenter Study PL - United States TA - Neurosurgery JT - Neurosurgery JID - 7802914 SB - IM MH - Adult MH - Aged MH - Female MH - *Health Surveys MH - Humans MH - Male MH - Middle Aged MH - *Minimal Clinically Important Difference MH - Neurosurgical Procedures/adverse effects/*methods MH - Nose MH - Pituitary Neoplasms/*surgery MH - Postoperative Complications/epidemiology/etiology MH - Prospective Studies MH - Quality of Life MH - Sella Turcica/*surgery MH - Skull Base/surgery MH - Young Adult EDAT- 2017/10/04 06:00 MHDA- 2019/09/17 06:00 CRDT- 2017/10/04 06:00 PHST- 2017/02/23 00:00 [received] PHST- 2017/06/19 00:00 [accepted] PHST- 2017/10/04 06:00 [pubmed] PHST- 2019/09/17 06:00 [medline] PHST- 2017/10/04 06:00 [entrez] AID - 4064761 [pii] AID - 10.1093/neuros/nyx401 [doi] PST - ppublish SO - Neurosurgery. 2018 Aug 1;83(2):277-280. doi: 10.1093/neuros/nyx401.